Literature DB >> 9393963

Tandem repeats of T helper epitopes enhance immunogenicity of fusion proteins by promoting processing and presentation.

M Kjerrulf1, B Löwenadler, C Svanholm, N Lycke.   

Abstract

Empirical findings have shown that recombinant chimeric proteins may be made more immunogenic if T helper epitopes are incorporated as tandem repeats. In the present study we investigated the mechanisms responsible for the enhanced immunogenicity of fusion proteins composed of the heat-stable enterotoxin of enterotoxigenic E. coli (STa) linked to multiple copies of the ovalbumin323-339 T helper epitope (ova) and a connecting dimer of an Ig-binding region of Staphylococcus aureus protein A (ZZ), which were previously shown to stimulate strong anti-STa titres in mice. We used B cell and macrophage cell lines as APC and IL-2 production by ova-specific T cells as our read-out system. Fusion proteins containing four repeated T helper epitopes were found to be the most immunogenic and resulted in 50-fold higher IL-2 production than constructs with a single T helper epitope. Under limiting APC conditions the construct with four epitopes was the best inducer of IL-2, indicating that this construct was most effectively processed by the APC. Analysis of IL-2R alpha expression by flow cytometry confirmed that four copies gave the highest frequency of activated T cells in culture, indicating a direct correlation between ability to activate T cells and IL-2 production in culture. Also in vivo, the fusion protein with four epitopes exhibited the strongest T cell priming effect. Moreover, both in vitro and in vivo, the ZZ construct was found to serve as an efficient means for targeting of the fusion proteins to B cells, thereby allowing access to the Ig receptor uptake pathway for Ag. The present study provides direct evidence that fusion proteins can be constructed to optimize processing in the individual APC and enhance activation of clonal T cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393963     DOI: 10.1016/s0161-5890(97)00078-3

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  Characterization of a permissive epitope insertion site in adenovirus hexon.

Authors:  Michael J McConnell; Xavier Danthinne; Michael J Imperiale
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.

Authors:  Monica Cabrera-Mora; Jairo Andres Fonseca; Balwan Singh; Joseli Oliveira-Ferreira; Josué da Costa Lima-Junior; J Mauricio Calvo-Calle; Alberto Moreno
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

3.  Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection.

Authors:  Jae-Rang Yu; Sol Kim; Jee-Boong Lee; Jun Chang
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

4.  Diagnostic peptide discovery: prioritization of pathogen diagnostic markers using multiple features.

Authors:  Santiago J Carmona; Paula A Sartor; María S Leguizamón; Oscar E Campetella; Fernán Agüero
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

5.  Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.

Authors:  A Lobell; R Weissert; M K Storch; C Svanholm; K L de Graaf; H Lassmann; R Andersson; T Olsson; H Wigzell
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

6.  Combinatorial contextualization of peptidic epitopes for enhanced cellular immunity.

Authors:  Masaki Ito; Kazumi Hayashi; Eru Adachi; Tamiko Minamisawa; Sadamu Homma; Shigeo Koido; Kiyotaka Shiba
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

7.  Production of antigen-specific human IgGs by in vitro immunization.

Authors:  A Wijkhuisen; A Savatier; N Cordeiro; M Léonetti
Journal:  BMC Biotechnol       Date:  2016-02-24       Impact factor: 2.563

8.  Generation of potent mouse monoclonal antibodies to self-proteins using T-cell epitope "tags".

Authors:  Jennifer L Percival-Alwyn; Elizabeth England; Benjamin Kemp; Laura Rapley; Nicola H E Davis; Grant R McCarthy; Jayesh B Majithiya; Dominic J Corkill; Sarah Welsted; Kevin Minton; E Suzanne Cohen; Matthew J Robinson; Claire Dobson; Trevor C I Wilkinson; Tristan J Vaughan; Maria A T Groves; Natalie J Tigue
Journal:  MAbs       Date:  2015       Impact factor: 5.857

9.  Virus like particles as a platform for cancer vaccine development.

Authors:  Hui Kian Ong; Wen Siang Tan; Kok Lian Ho
Journal:  PeerJ       Date:  2017-11-15       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.